Nonmelanoma skin cancer (NMSC) is the most common type of skin cancer in the United States.
Methods | After institutional review board approval was obtained from Indiana University, a database was created of patients presenting to the Richard L. Roudebush VA Medical Center for treatment of NMSC over a 10-month period. Consent was not indicated for a retrospective deidentified data set. All patients had shave biopsy-proven basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) with positive margins. Collected variables included age, type and location of cancer, size of lesion, personal history of skin cancer, history of tobacco use, length of time from biopsy to excision, and final pathology. Attending and resident physicians independently evaluated the postbiopsy lesion for the suspected clinical presence of residual carcinoma after biopsy. Cancer clearance was defined as no residual carcinoma present in the excisional specimen at final pathology. Statistical analysis was performed using the t test, and significance was set at P < .05. . No patient-specific risk factors were identified. There was a trend toward clearance of lesions with longer wait times between biopsy and excision, which suggests that close clinical surveillance may be appropriate for some low-risk lesions. Surgeons had difficulty predicting the persistence of cancer based on the appearance of the biopsy scar alone, regardless of experience. Future studies are needed to determine additional patient and lesion characteristics that contribute to clearance of NMSC after biopsy. Intraoperative neuromonitoring using specific stimulation of the more proximal vagus nerve is thought to provide more complete anatomic analysis of RLN integrity than that of isolated distal segments of the RLN alone. 4 However, current vagal IONM methods typically entail placing an electrode around the vagus for continuous electrical stimulation. This requires additional dissection of, and fixation to, the 
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